How can Candida colonisation (CV) be distinguished from vulvovaginal candidiasis (VVC)?

Distinguishing Candida Colonization from Vulvovaginal Candidiasis

The key distinction between Candida colonization (CV) and vulvovaginal candidiasis (VVC) is the presence of symptoms—VVC requires both positive Candida detection AND clinical symptoms (itching, burning, abnormal discharge, erythema), while colonization is asymptomatic yeast presence.

Clinical Presentation: The Primary Differentiator

Symptomatic VVC presents with:

• Vaginal itching and burning 1
• Vulvar erythema and edema 1
• Abnormal vaginal discharge (typically thick, white, "cottage cheese-like") 1
• Dyspareunia and dysuria 1

Asymptomatic colonization:

• Positive Candida culture or detection without any clinical symptoms 2
• Studies show 21% of healthy controls have positive Candida cultures without symptoms 3

Diagnostic Approach

The Critical Pitfall

Less than half of patients treated for VVC are actually diagnosed with an objective assay 4. This leads to massive overtreatment of colonization as if it were infection.

Recommended Diagnostic Algorithm

1. Clinical assessment first: Document specific symptoms (itching, burning, discharge characteristics) 1

2. Microscopy limitations:

   • Poor sensitivity (only 57.5%) 4
   • Approximately 50% of infected patients have negative microscopy 4
   • Cannot distinguish colonization from infection—only shows yeast presence 4

3. Culture considerations:

   • Takes 48-72 hours minimum 4
   • Positive culture alone does NOT equal VVC—must correlate with symptoms 2
   • Studies demonstrate non-albicans species occur in 61.5% of asymptomatic women versus 38.7% in symptomatic VVC 2

4. PCR testing (preferred when available):

   • Superior sensitivity (90.7%) and specificity (93.6%) compared to clinical diagnosis 4
   • For Candida group: PPV 87.2%, NPV 95.5% 4
   • Still requires symptom correlation for VVC diagnosis 4

Key Distinguishing Features

Strain Behavior Differences

Recent research identifies that VVC-associated strains induce significantly more fungal shedding and epithelial cell detachment compared to colonizing strains 5. VVC strains differentially activate epithelial signaling pathways, including suppressed type I interferon responses 5.

Species Distribution

• C. albicans: Most common in both groups (38-39% in VVC and colonization) 3
• Non-albicans species: More frequently associated with asymptomatic colonization (61.5%) than VVC (38.7%) 2
• C. glabrata, C. dubliniensis, and C. krusei occur at similar rates in both groups 3, 6

Treatment Decision Framework

DO NOT TREAT asymptomatic colonization 4. Treatment is indicated only when:

• Positive Candida detection (microscopy, culture, or PCR) AND
• Documented clinical symptoms consistent with VVC 4, 1

Common Clinical Errors to Avoid

• Treating positive cultures without symptoms leads to unnecessary antifungal exposure and potential resistance 4
• Relying on clinical diagnosis alone results in misdiagnosis in >50% of cases 4
• Assuming all vaginal symptoms with yeast present equals VVC—must exclude other causes (bacterial vaginosis, trichomoniasis, dermatoses) 7

Special Considerations

Extragenital colonization: In women with recurrent VVC, 51% have Candida at extragenital sites (mouth 13%, rectum 28%, perianal skin 41%) 8. However, this colonization rate is significantly higher when genital cultures are also positive (74% perianal colonization in vaginal culture-positive women) 8.

Pregnancy and hormonal factors: Estrogen-dependent changes increase both colonization rates and progression to symptomatic VVC 7, 9. Pregnant women show higher VVC prevalence due to hormonal changes, but asymptomatic colonization also increases 9.